Acquired Brain Injury, Adults, Occupational Therapy
Conditions
Brief summary
Purpose: to observe the possible benefits produced by conventional therapy through virtual reality with the Nintendo Switch to try to improve motivation and increase the degree of care satisfaction. The aim is to improve postural control in both seated and standing positions and to maintain and improve cognitive capacity. Material and methods: one group (experimental group) will receive a total of 8 one-hour sessions or 16 half-hour sessions, depending on their individual needs, for 8 weeks using the Nintendo Switch. The other group (control group) will continue to receive their conventional scheduled therapy. Measures: Abilhand, MEC-Lobo, FIST, Fugl-Meyer, Berg Balance Scale and CSQ-8.
Interventions
Conventional sessions are neuropsychology, speech therapy, physiotherapy and occupational therapy treatments. They are based on cognitive stimulation, manipulative dexterity, therapeutic exercise.
Conventional sessions are neuropsychology, speech therapy, physiotherapy and occupational therapy treatments. They are based on cognitive stimulation, manipulative dexterity, therapeutic exercise plus one hour a week of Nintendo Switch.
Sponsors
Study design
Intervention model description
Control Group (CG), which received their usual sessions of conventional therapy sessions, and an Experimental Group (EG), which received therapy with Nintendo Switch plus their conventional therapy sessions.
Eligibility
Inclusion criteria
* Adult men and women, over 30 years of age who have suffered an acquired brain injury. * Mild or moderate cognitive impairment as measured by the MEC-Lobo test (score greater than 23/35). * Regularly attend some conventional therapy (neuropsychology, physiotherapy or occupational therapy). * Agree to participate voluntarily by signing the informed consent form.
Exclusion criteria
* Present severe cognitive impairment as measured by the MEC-Lobo test (less than 23/35). * Present aphasia of comprehension or expression. * Present associated neurodegenerative pathology. * Present any pathology underlying the acquired brain damage (diabetes, heart disease, COPD, etc.), heart disease, COPD, etc.). * Voluntarily refuse to participate in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Abilhand | Pre-intervention and post-intervention (up to 1-2 weeks) | It is an assessment test that measures the degree of difficulty perceived by the patient in performing the 23 activities of daily living. |
| MEC-Lobo | Pre-intervention and post-intervention (up to 1-2 weeks) | This is a scale that allows us to evaluate the cognitive status of patients. The lower the score, the greater the cognitive impairment. |
| Function in Sitting Test (FIST) | Pre-intervention and post-intervention (up to 1-2 weeks) | It is a scale that assesses the postural control deficits presented by the patient in sedentary position in the event of imbalance, reaching on the floor, etc. |
| Fugl-Meyer | Pre-intervention and post-intervention (up to 1-2 weeks) | This scale assesses the patient's motor function, sensory function, muscle balance, range of joint mobility and joint pain. |
| Berg Balance Scale (BBS) | Pre-intervention and post-intervention (up to 1-2 weeks) | The scale is used to measure balance mainly in standing position in patients with different types of pathologies. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Client Satisfaction Questionnaire (CSQ-8) | Post-intervention (up to 1-2 weeks) | Self-administered questionnaire that evaluates the level of satisfaction in relation to the care and quality of care received. |
Countries
Spain